Is VERA or VIVS more undervalued in 2026?

CirclFi compares Vera Therapeutics, Inc. (VERA) and VivoSim Labs, Inc. (VIVS) using 13 institutional-grade valuation models. VERA has a Quality of Company score of 4.6/10 while VIVS scores 4.5/10.

Which is a better buy — VERA or VIVS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do VERA and VIVS valuations compare?

VERA at $35.86 and VIVS at $1.31 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

VERA vs VIVS Valuation Comparison 2026 — Intrinsic Value Analysis

VERA

Biotechnology

Vera Therapeutics, Inc.

Quality

4.6

out of 10

Value Trap

SAFE

Price

$35.86

Last close

Models

10/13

Active

VIVS

Biotechnology

VivoSim Labs, Inc.

Quality

4.5

out of 10

Value Trap

LOW

Price

$1.31

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	VERA Fair Value	VERA Upside	VIVS Fair Value	VIVS Upside
Bayesian DCF	Intrinsic	$11.25	-68.6%	$1.03	-21.2%
Earnings Power Value	Intrinsic	$15.75	-58.2%	$3.09	+114.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for VERA vs VIVS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VERA vs VIVS — Which Stock Is More Undervalued?

VERA scores higher with a 4.6/10 quality rating vs VIVS's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Vera Therapeutics, Inc. (VERA) and VivoSim Labs, Inc. (VIVS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VERA currently trades at $35.86 with a QOC of 4.6/10, while VIVS trades at $1.31 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).